Gunjan Shah, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
PI on 3 trials 1 publication
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing dataRare diseases treated or studied
Based on trial PI assignments and publication topics.
Clinical trials (3)
Verify independently
Other specialists for Post-transplant lymphoproliferative disease
Peers ranked by clinical-trial PI role, publications, and verification quality.
- Birte Wistinghausen, M.DChildren's Oncology GroupNY
- Aurore PERROT, ProfIUCT Toulouse France
- Cyrille TOUZEAU, ProfCHU Nantes France
- Kurt Gunter, MD, M.DInozyme Pharma, Inc.MA
- David MaloneyFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
- Corey Cutler, MD, MPH, F.N.PDana-Farber Cancer InstituteUT
- Chanaz LOUNIThe Institute for Functional Medicine
- Leona HolmbergFred Hutch/University of Washington Cancer ConsortiumWA
See all specialists for Post-transplant lymphoproliferative disease →